EP1080185A4 - Peptides de proteine basique de myeline et utilisations de ceux-ci - Google Patents
Peptides de proteine basique de myeline et utilisations de ceux-ciInfo
- Publication number
- EP1080185A4 EP1080185A4 EP99920379A EP99920379A EP1080185A4 EP 1080185 A4 EP1080185 A4 EP 1080185A4 EP 99920379 A EP99920379 A EP 99920379A EP 99920379 A EP99920379 A EP 99920379A EP 1080185 A4 EP1080185 A4 EP 1080185A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- basic protein
- myelin basic
- protein peptides
- peptides
- myelin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 title 1
- 102000047918 Myelin Basic Human genes 0.000 title 1
- 101710107068 Myelin basic protein Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Rehabilitation Therapy (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7310998A | 1998-05-05 | 1998-05-05 | |
| US73109 | 1998-05-05 | ||
| PCT/US1999/009930 WO1999057241A2 (fr) | 1998-05-05 | 1999-05-05 | Peptides de proteine basique de myeline et utilisations de ceux-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1080185A2 EP1080185A2 (fr) | 2001-03-07 |
| EP1080185A4 true EP1080185A4 (fr) | 2005-01-26 |
Family
ID=22111789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99920379A Withdrawn EP1080185A4 (fr) | 1998-05-05 | 1999-05-05 | Peptides de proteine basique de myeline et utilisations de ceux-ci |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1080185A4 (fr) |
| JP (1) | JP2002513558A (fr) |
| CN (1) | CN1308671A (fr) |
| AU (1) | AU3789099A (fr) |
| CA (1) | CA2330826A1 (fr) |
| HK (1) | HK1039636A1 (fr) |
| NO (1) | NO20005547L (fr) |
| NZ (1) | NZ507901A (fr) |
| WO (1) | WO1999057241A2 (fr) |
| ZA (1) | ZA200006268B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1487480B1 (fr) * | 2001-05-01 | 2015-10-07 | The Regents of The University of California | Molecules hybrides pour le traitement des maladies immunitaires |
| US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| ITFI20010114A1 (it) | 2001-06-22 | 2002-12-22 | Univ Firenze | Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla |
| ES2627306T3 (es) * | 2007-11-20 | 2017-07-27 | Vianex S.A. | Análogos de péptido y conjugados de los mismos |
| KR20170126001A (ko) * | 2015-03-30 | 2017-11-15 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 면역용 펩티드, 면역용 펩티드의 제조 방법, 그것을 포함하는 면역 질환용 의약 조성물, 및 면역 질환의 치료 방법 |
| WO2020257221A1 (fr) * | 2019-06-18 | 2020-12-24 | The Scripps Research Institute | Procédés et compositions pour le traitement d'états inflammatoires |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996012737A2 (fr) * | 1994-10-25 | 1996-05-02 | Immulogic Pharmaceutical Corporation | Compositions et traitement pour la sclerose en plaques |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
| CA2224205A1 (fr) * | 1995-06-07 | 1996-12-19 | Zymogenetics, Inc. | Complexes solubles d'heterodimeres de lmh fusionnes et de peptides, et leur utilisation |
-
1999
- 1999-05-05 JP JP2000547197A patent/JP2002513558A/ja active Pending
- 1999-05-05 AU AU37890/99A patent/AU3789099A/en not_active Abandoned
- 1999-05-05 CA CA002330826A patent/CA2330826A1/fr not_active Abandoned
- 1999-05-05 HK HK02101092.3A patent/HK1039636A1/zh unknown
- 1999-05-05 EP EP99920379A patent/EP1080185A4/fr not_active Withdrawn
- 1999-05-05 WO PCT/US1999/009930 patent/WO1999057241A2/fr not_active Ceased
- 1999-05-05 NZ NZ507901A patent/NZ507901A/xx unknown
- 1999-05-05 CN CN99808248A patent/CN1308671A/zh active Pending
-
2000
- 2000-11-02 ZA ZA200006268A patent/ZA200006268B/en unknown
- 2000-11-03 NO NO20005547A patent/NO20005547L/no not_active Application Discontinuation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996012737A2 (fr) * | 1994-10-25 | 1996-05-02 | Immulogic Pharmaceutical Corporation | Compositions et traitement pour la sclerose en plaques |
Non-Patent Citations (2)
| Title |
|---|
| See also references of WO9957241A3 * |
| WUCHERPFENNIG K W ET AL: "STRUCTURAL REQUIREMENTS FOR BINDING OF AN IMMUNODOMINANT MYELIN BASIC PROTEIN PEPTIDE TO DR2 ISOTYPES AND FOR ITS RECOGNITION BY HUMAN T CELL CLONES", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 179, no. 1, January 1994 (1994-01-01), pages 279 - 290, XP000655184, ISSN: 0022-1007 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1080185A2 (fr) | 2001-03-07 |
| WO1999057241A2 (fr) | 1999-11-11 |
| JP2002513558A (ja) | 2002-05-14 |
| ZA200006268B (en) | 2001-08-22 |
| CA2330826A1 (fr) | 1999-11-11 |
| WO1999057241A9 (fr) | 2000-02-17 |
| WO1999057241A3 (fr) | 2000-01-13 |
| CN1308671A (zh) | 2001-08-15 |
| NO20005547D0 (no) | 2000-11-03 |
| NZ507901A (en) | 2003-06-30 |
| NO20005547L (no) | 2001-01-02 |
| HK1039636A1 (zh) | 2002-05-03 |
| AU3789099A (en) | 1999-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL346346A1 (en) | Cyclic prosaposin-derived peptides and uses thereof | |
| HUP0102535A3 (en) | Cd19xcd3 specific polypeptides and uses thereof | |
| HUP0200414A2 (en) | Interferon-betha fusion proteins and uses | |
| GB9806806D0 (en) | Peptides and uses thereof | |
| AU5340399A (en) | Proteases and associated proteins | |
| GB9719879D0 (en) | Protein | |
| AP2001002189A0 (en) | Genes and proteins and their uses | |
| IL131707A0 (en) | Acetylcholinesterase-derived peptides and uses thereof | |
| EP1140976A4 (fr) | Proteines secretees et leurs utilisations | |
| GB9718110D0 (en) | Peptides | |
| ZA985999B (en) | Protein kinases and uses thereof | |
| GB9918155D0 (en) | Proteins and peptides | |
| EP1080185A4 (fr) | Peptides de proteine basique de myeline et utilisations de ceux-ci | |
| GB9700154D0 (en) | Peptides | |
| GB9714276D0 (en) | Peptides and related compounds | |
| IL137493A0 (en) | Svph3-13 and spvh3-17 dna and polypeptides | |
| GB9720784D0 (en) | Protein | |
| GB9828880D0 (en) | Protein | |
| EP1142999A4 (fr) | Proteine et adn associe | |
| GB9824357D0 (en) | Protein and DNA coding therefor | |
| EP1111047A4 (fr) | Nouvelle proteine et son adn | |
| EP1132472A4 (fr) | Nouvelle proteine et son utilisation | |
| GB9809566D0 (en) | Protein | |
| EP1141269A4 (fr) | Proteines secretees et leurs utilisations | |
| NZ513920A (en) | Novel proteins and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20001130 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20041215 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20040602 |